Anti-TAFA1/ FAM19A1/ TAFA-1 functional antibody

Anti-TAFA1/ FAM19A1/ TAFA-1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FAM19A1/FAM19A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0194-Ab-1/ GM-Tg-hg-SE0194-Ab-2Anti-Human FAM19A1 monoclonal antibodyHuman
GM-Tg-rg-SE0194-Ab-1/ GM-Tg-rg-SE0194-Ab-2Anti-Rat FAM19A1 monoclonal antibodyRat
GM-Tg-mg-SE0194-Ab-1/ GM-Tg-mg-SE0194-Ab-2Anti-Mouse FAM19A1 monoclonal antibodyMouse
GM-Tg-cynog-SE0194-Ab-1/ GM-Tg-cynog-SE0194-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM19A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0194-Ab-1/ GM-Tg-felg-SE0194-Ab-2Anti-Feline FAM19A1 monoclonal antibodyFeline
GM-Tg-cang-SE0194-Ab-1/ GM-Tg-cang-SE0194-Ab-2Anti-Canine FAM19A1 monoclonal antibodyCanine
GM-Tg-bovg-SE0194-Ab-1/ GM-Tg-bovg-SE0194-Ab-2Anti-Bovine FAM19A1 monoclonal antibodyBovine
GM-Tg-equg-SE0194-Ab-1/ GM-Tg-equg-SE0194-Ab-2Anti-Equine FAM19A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0194-Ab-1/ GM-Tg-hg-SE0194-Ab-2; GM-Tg-rg-SE0194-Ab-1/ GM-Tg-rg-SE0194-Ab-2;
GM-Tg-mg-SE0194-Ab-1/ GM-Tg-mg-SE0194-Ab-2; GM-Tg-cynog-SE0194-Ab-1/ GM-Tg-cynog-SE0194-Ab-2;
GM-Tg-felg-SE0194-Ab-1/ GM-Tg-felg-SE0194-Ab-2; GM-Tg-cang-SE0194-Ab-1/ GM-Tg-cang-SE0194-Ab-2;
GM-Tg-bovg-SE0194-Ab-1/ GM-Tg-bovg-SE0194-Ab-2; GM-Tg-equg-SE0194-Ab-1/ GM-Tg-equg-SE0194-Ab-2
Products NameAnti-FAM19A1 monoclonal antibody
Formatmab
Target NameFAM19A1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FAM19A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0194-Ag-1Recombinant multi-species TAFA1/ FAM19A1/ TAFA-1 protein


    Target information

    Target IDGM-SE0194
    Target NameFAM19A1
    Gene ID407738,320265,500266,697220,611001,101091180,782935,100053538
    Gene Symbol and SynonymsC630007B19Rik,FAM19A1,FAM19A1 TAFA-1,RGD1563030,TAFA-1,TAFA1
    Uniprot AccessionQ7Z5A9
    Uniprot Entry NameTAFA1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183662
    Target ClassificationN/A

    The target: FAM19A1, gene name: FAM19A1, also named as TAFA-1, TAFA1. This gene is a member of the TAFA family which is composed of five highly homologous genes that encode small secreted proteins. These proteins contain conserved cysteine residues at fixed positions, and are distantly related to MIP-1alpha, a member of the CC-chemokine family. The TAFA proteins are predominantly expressed in specific regions of the brain, and are postulated to function as brain-specific chemokines or neurokines that act as regulators of immune and nervous cells. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.